EMG
KYNB

Ellington Management Group’s Kyntra Bio KYNB Stock Holding History

Ellington Management Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-376
Closed -$403K – 613
2019
Q4 		$403K Buy
376
+148
+65% +$151K 0.09% 229
2019
Q3 		$211K Buy
+228
New +$250K 0.04% 494
2019
Q1 		– Sell
-352
Closed -$407K – 599
2018
Q4 		$407K Buy
+352
New +$396K 0.12% 183
2018
Q2 		– Sell
-412
Closed -$476K – 610
2018
Q1 		$476K Buy
+412
New +$543K 0.03% 422

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Ellington Management Group's KYNB Position: Q1 2020 in Review

Ellington Management Group sold out of Kyntra Bio (KYNB) in Q1 2020, closing a stake of 376 shares — an estimated $403K sold.

Ellington Management Group first reported a position in KYNB in Q1 2018 and held it in 4 quarters. The position peaked at $476K in Q1 2018. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

  • Ellington Management Group reported no remaining Kyntra Bio position as of Q1 2020 after selling out during the quarter.
  • Ellington Management Group sold 376 Kyntra Bio shares in Q1 2020, an estimated $403K.
  • Ellington Management Group first reported a position in Kyntra Bio in Q1 2018 and held it in 4 quarters.
  • Ellington Management Group's Kyntra Bio position peaked at $476K in Q1 2018.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.